Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
PDS Biotechnology Corp | Chief Financial Officer | Common Stock | 17.6K | $173K | $9.78 | Jun 15, 2021 | Direct |
NRX Pharmaceuticals, Inc. | CHIEF FINANCIAL OFFICER | Common Stock, par value $0.001 per share | 46.3K | $14.8K | $0.32 | Dec 16, 2022 | Direct |
NRX Pharmaceuticals, Inc. | CHIEF FINANCIAL OFFICER | Common Stock, par value $0.001 per share | 16.4K | $5.24K | $0.32 | Nov 25, 2022 | Shares purchased though 401(k) plan |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NRXP | NRX Pharmaceuticals, Inc. | Dec 16, 2022 | 1 | $33K | 4 | Dec 19, 2022 | CHIEF FINANCIAL OFFICER |
NRXP | NRX Pharmaceuticals, Inc. | Nov 25, 2022 | 3 | $18.2K | 4/A | Dec 19, 2022 | CHIEF FINANCIAL OFFICER |
NRXP | NRX Pharmaceuticals, Inc. | Jun 13, 2022 | 0 | $0 | 3 | Jun 29, 2022 | Chief Financial Officer |
PDSB | PDS Biotechnology Corp | Jun 15, 2021 | 1 | $150K | 4 | Jun 17, 2021 | Chief Financial Officer |